Why Is Motilal Oswal Confident on Atul Ltd’s Growth Outlook Through FY28?
Motilal Oswal Financial Services (MOSL) has reiterated its Buy recommendation on Atul Ltd with a target price of ₹7,520, signaling optimism about the company’s structural earnings resilience and volume growth momentum. The brokerage’s confidence stems from the balanced performance across both Performance Chemicals and Life Science Chemicals divisions, alongside margin discipline and sustained demand recovery in global markets.
In its latest quarterly update, MOSL reported that Atul Ltd’s revenue stood at ₹1,550 crore, marking an 11% year-on-year increase — largely in line with expectations. The chemical manufacturer continues to benefit from improved realizations and strong order flows, particularly in downstream specialty segments.
Looking for research-backed ideas during result season? Don’t miss our expert Nifty Option Tip curated by certified market analysts to help you trade smartly.
The report highlights that Performance Chemicals rose by 12% YoY and Life Science Chemicals grew by 8% YoY, demonstrating strong traction across verticals. MOSL notes that Atul’s product mix optimization, expansion into higher-margin chemistries, and operational efficiency gains have collectively supported growth in both top-line and profitability metrics.
Atul Ltd Q2 FY26 Key Financial Metrics
| Metric | Value | YoY Change |
|---|---|---|
| Revenue | ₹1,550 crore | +11% |
| EBITDA | ₹270 crore | +10% |
| PAT | ₹180 crore | +31% |
| P/E (FY27E) | ~23.8x | On EPS of ₹250.5 |
| EV/EBITDA (FY27E) | ~14.3x | Stable Valuation |
Atul Ltd’s consistent cash flow generation, strong balance sheet, and strategic capital allocation are driving investor confidence. The company’s focus on downstream integration and import substitution has helped mitigate raw material volatility and improve cost efficiency.
Motilal Oswal expects Atul Ltd to deliver a 12% revenue CAGR, 14% EBITDA CAGR, and 17% PAT CAGR over FY25–FY28E. The brokerage maintains FY26–28 estimates, underscoring stable demand visibility across both domestic and export segments. The target valuation of ₹7,520 is derived by applying a 30x multiple to FY27E EPS.
Stay aligned with market momentum and index moves by following our live BankNifty Intraday Tip for actionable intraday insights.
Beyond short-term performance, MOSL sees Atul as a long-term compounder with a strong moat in value-added chemicals and specialty intermediates. The company’s recent capacity expansion and innovation-led portfolio diversification in crop protection, dyes, and polymers segments are expected to sustain profitability even amid global demand fluctuations.
Analysts believe that Atul’s diversified product mix and consistent reinvestment strategy will keep return ratios healthy. Its efficient capital deployment continues to support earnings compounding without the need for excessive leverage.
Investor Takeaway
Indian-Share-Tips.com Nifty Expert Gulshan Khera, CFP®, who is also a SEBI Regd Investment Adviser, observes that Atul Ltd exemplifies a high-quality chemical franchise with sustainable profitability and prudent capital management. The company’s track record of steady growth through cyclical phases makes it a preferred pick among diversified chemical players.
While valuations appear rich, they reflect Atul’s strong cash generation, expansion visibility, and margin stability. Investors with a long-term horizon may consider accumulation on dips to benefit from compounding potential in specialty chemicals.
Discover more expert-driven investment analysis and insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Related Queries on Atul Ltd Analysis
- What Drives Motilal Oswal’s Optimism on Atul Ltd?
- How Is Atul Ltd Managing Growth Across Performance and Life Science Chemicals?
- Is Atul Ltd a Sustainable Compounder in Specialty Chemicals?
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
